However, under many pathophysiological states, such as diabetes, obesity, IR injury and aging, there is a shift in equilibrium favoring more sEH-dependent inflammatory pathways [60]. Here, EPHX2 is linked to obesity due to melanocortin 4 receptor deficiency.